Zavesca and Zykadia

• Generic Name: miglustat
• Dosage Forms: capsule
• Other Brand Names: Zavesca

Zavesca (miglustat) reduces the formation of a certain protein in the body in people with type 1 Gaucher disease.

Gaucher disease is a genetic condition in which the body lacks the enzyme needed to break down certain fatty materials (lipids). Lipids can build up in the body, causing symptoms such as easy bruising or bleeding, weakness, anemia, bone or joint pain, enlarged liver or spleen, or weakened bones that are easily fractured.

Zavesca is used to treat mild to moderate type 1 Gaucher disease by people who cannot receive enzyme replacement therapy.

Zavesca may improve the condition of the liver, spleen, bones, and blood cells in people with Type I Gaucher disease. However, it is not a cure for this condition.

Zavesca may also be used for purposes not listed in this medication guide.

• Generic Name: ceritinib
• Dosage Forms: capsule
• Other Brand Names: Zykadia

Zykadia (ceritinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Zykadia is used to treat non-small cell lung cancer that has spread to other parts of the body.

Zykadia is used only if your cancer has a specific genetic marker. Your doctor will test you for this gene.